EQT Nears €9.6 Billion Deal for Molecular Testing Firm Qiagen

bloomberg

·

Original Report

↗ bloomberg

EQT AB is nearing a deal to acquire Qiagen NV for around €9.6 billion ($10.8 billion) bringing an end to years of takeover speculation involving the European molecular testing company, according to people familiar with the matter.